NDC11 50268076515
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 50268-0765-15 | 50268-0765 |
| 50268-765-15 | 50268-765 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Terazosin | TERAZOSIN HYDROCHLORIDE | AvPAK | 9e7b27a6-cc09-407e-e053-2a95a90a17b3 | 2025-07-02 | Warnings, Adverse reactions | 50268-765-15 50268-765 50268076515 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.